(Q54729777)

3 June 2018

title

MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers. (English)

1 reference

3 June 2018

6

Holger Moch

1 reference

3 June 2018

author name string

Pirus Ghadjar

1

1 reference

3 June 2018

Wieslawa Blank-Liss

2

1 reference

3 June 2018

Mathew Simcock

3

1 reference

3 June 2018

Ivan Hegyi

4

1 reference

3 June 2018

Karl T Beer

5

1 reference

3 June 2018

Daniel M Aebersold

7

1 reference

3 June 2018

Yitzhak Zimmer

8

1 reference

3 June 2018

publication date

29 July 2009

1 reference

3 June 2018

Clinical & Experimental Metastasis

published in

1 reference

3 June 2018

volume

26

1 reference

3 June 2018

issue

7

1 reference

3 June 2018

page(s)

809-815

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1007/s10585-009-9280-9

exact match

0 references

cites work

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-009-9280-9

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

21 January 2018

1 reference

12 December 2020

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

12 December 2020

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas

1 reference

12 December 2020

Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1.

1 reference

12 December 2020

Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx

1 reference

12 December 2020

Drug development of MET inhibitors: targeting oncogene addiction and expedience

1 reference

12 December 2020

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

12 December 2020

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

12 December 2020

Met, metastasis, motility and more

1 reference

12 December 2020

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus

1 reference

12 December 2020

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head

1 reference

12 December 2020

Targeting the c-Met signaling pathway in cancer

1 reference

12 December 2020

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

1 reference

12 December 2020

Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma

1 reference

12 December 2020

Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer

1 reference

12 December 2020

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

1 reference

12 December 2020

The MET receptor tyrosine kinase in invasion and metastasis

1 reference

12 December 2020

Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up.

1 reference

12 December 2020

Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Silencing the MET oncogene leads to regression of experimental tumors and metastases

1 reference

12 December 2020

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.

1 reference

12 December 2020

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

12 December 2020

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

12 December 2020

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo

1 reference

12 December 2020

10.1007/S10585-009-9280-9

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018